A pilot study found sex differences in endocannabinoid tone during cannabis use disorder and acute abstinence, with implications for developing sex-specific treatments.
Addiction researchers, CUD clinicians, pharmacotherapy developers, and precision medicine advocates.
Sex differences foundMen and women with CUD showed different endocannabinoid profiles during use and abstinence
What the researchers found
Men and women with CUD showed different endocannabinoid system profiles during active use and acute abstinence, suggesting that pharmacotherapies targeting the endocannabinoid system may need to account for biological sex.
Why it matters
CUD presents differently in men and women, particularly in withdrawal symptoms. Understanding underlying sex differences in endocannabinoid function could enable more effective, personalized treatments.
The numbers in context
Pilot study examining endocannabinoid tone differences between men and women with cannabis use disorder during active use and acute abstinence.
How the study worked
Pilot clinical study measuring endocannabinoid levels in men and women with CUD during active use and acute cannabis abstinence.
Who was studied
Men and women with cannabis use disorder assessed during active use and acute abstinence.
What this study cannot tell us
Pilot study with small sample size; endocannabinoid levels measured peripherally may not reflect central nervous system levels; confounding factors like menstrual cycle phase.
How to read the evidence
Pilot study provides preliminary evidence; small sample requires replication in larger studies.
When this study was published
Recent pilot study opening a new line of sex-specific CUD research.
The bigger picture
As the field moves toward precision medicine for addiction, understanding sex-based differences in the endocannabinoid system is essential for developing pharmacotherapies that work for everyone.
Replication
Pilot data; among the first studies examining sex-specific eCB profiles in CUD.
Funding
Not specified
Conflicts of interest
Not specified
Questions still open
- How do endocannabinoid levels change over extended abstinence?
- Do hormonal fluctuations affect eCB differences?
- Could eCB-targeted treatments work differently by sex?
Read the original research
Sex differences in endocannabinoid tone in a pilot study of cannabis use disorder and acute cannabis abstinence.
Addiction biology, 28(10), e13337
Citation
Martin, Erin L; Baker, Nathaniel L; Sempio, Cristina; Christians, Uwe; Klawitter, Jost; McRae-Clark, Aimee L. (2023). Sex differences in endocannabinoid tone in a pilot study of cannabis use disorder and acute cannabis abstinence.. Addiction biology, 28(10), e13337. https://doi.org/10.1111/adb.13337